India Pharma Outlook Team | Friday, 03 April 2026
Emami has signed a deal to acquire full stake in Axiom Ayurveda, marking its entry into the fast-growing health and wellness beverage segment.
The company announced on April 1, 2026, that it will buy the remaining 73.5 percent stake in Axiom in a phased transaction.
Emami has already acquired an additional 36.7 percent stake in the first tranche, taking its total holding to 63.2 percent. The remaining stake will be picked up over the next three months, subject to regulatory approvals and customary conditions. The total deal value will not exceed Rs 200 crore, and the board has approved the acquisition.
Also Read: How Emerging Biotech Startups Reshaping the Bioprocessing Future
With this move, Emami is stepping into the health drinks market, tapping into rising demand for functional and natural beverages. Axiom’s portfolio includes aloe vera-based drinks sold under the “AloFrut” brand, ayurvedic juices branded as “Axiom Jeevan Ras,” and personal care products under “Mukti Gold.”
AloFrut, the company’s flagship range, combines aloe vera pulp with fruit flavors and is positioned as a healthier alternative to traditional beverages. The brand has established distribution across general trade channels and government institutions.
“Our growth strategy is centered on building presence in emerging, high-opportunity categories that align with evolving consumer preferences, particularly in the health and wellness space. Our partnership with Axiom over the past two and half years has provided us with valuable insights and strengthened our conviction in this segment," said Harsha Vardhan Agarwal, Vice Chairman and Managing Director of Emami.
"Axiom is a profitable and growing company, expected to achieve a topline of around Rs.180 crore in FY26. This aligns with our strategy of leveraging multiple growth levers, where strategic investments in newage, synergistic segments complement our core businesses to drive future growth," he added.
